Conception, Synthesis, and Characterization of a Rofecoxib-Combretastatin Hybrid Drug With Potent Cyclooxygenase-2 (COX-2) Inhibiting and Microtubule Disrupting Activities in Colon Cancer Cell Culture and Xenograft Models

Oncotarget - United States
doi 10.18632/oncotarget.25450

Related search